TNFα, an inflammatory cytokine known to be involved in the modulation of numerous signaling pathways [29] and exhibiting dysregulated expression in several neoplastic diseases [30], displayed a remarkable seven-fold increase in primary cancer cells derived from patients with a higher number of L-TAMs compared to S-TAMs. This evidence concerns the gene TNF and cancer.